Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2018 Dec 10;13(12):e0202243. doi: 10.1371/journal.pone.0202243

Genetic diversity of the enteroviruses detected from cerebrospinal fluid (CSF) samples of patients with suspected aseptic meningitis in northern West Bank, Palestine in 2017

Kamal Dumaidi 1,*,#, Amer Al-Jawabreh 1,2,#, Fekri Samarah 1, Areej Zraiqi 1, Dirgham Yaseen 3
Editor: Zhefeng Meng4
PMCID: PMC6287809  PMID: 30532168

Abstract

Background

Human enterovirus genus showed a wide range of genetic diversity.

Objectives

To investigate the genetic diversity of the enteroviruses isolated in 2017 in northern West Bank, Palestine.

Study design

249 CSF samples from aseptic meningitis cases were investigated for HEV using two RT-PCR protocols targeting the 5’ NCR and the VP1 region of the HEV genome. The phylogenetic characterization of the sequenced VP1 region of Echovirus18 (E18) and Coxsackievirus B5 (CVB5) isolated in Palestine along with 27 E18 and 27 CVB5 sequences available from the Genbank were described.

Results

E18 and CVB5 account for 50% and 35% of the successfully HEV types, respectively. Phylogenetic tree of E18 and CVB5 showed three main clusters, with all Palestinian isolates uniquely clustering together with those from China and from different countries, respectively. Cluster I of E18, with 13 Palestinian and 6 Chinese isolates, showed the lowest haplotype-to-sequence ratio (0.6:1), haplotype diversity (Hd), nucleotide diversity (π), and number of segregating sites (S) compared to clusters II and III. Furthermore, cluster I showed negative Tajima’s D and Fu-Li’sF tests with statistically significant departure from neutrality (P<0.01). In both E18 and CVB5 populations, high haplotype diversity, but low genetic diversity was evident. Inter-population pairwise genetic distance (Fst) and gene flow (Nm) showed that the Palestinian E18 and CVB5 clusters were highly differentiated from the other clusters.

Conclusions

The study divulged close genetic relationship between Palestinian HEV strains as confirmed by population genetics and phylogenetic analyses.

Background

Human enterovirus (HEV) is a non-enveloped RNA genus of the family Picornaviridae with genera and 116 species and more than 111 serotypes/genotypes in genus enterovirus [12]. HEV is divided into 4 HEV species designated HEVA to D, based on the sequences analysis of the partial or complete VP1 region of the viral genome [3]. The VP1 are immunodominant capsid proteins that contain the neutralization antigenic determinants which correlate well with serotyping and are used for HEV genotyping [4].

HEVs are associated with several diverse clinical manifestations including mild febrile illness, gastroenteritis, respiratory tract infection, neonatal sepsis-like illness and aseptic meningitis as the most frequent infections caused by HEV that occurs as sporadic and/or outbreaks of varying size. HEV-B causing aseptic meningitis include echoviruses, some enteroviruses coxsachievirus B [57]. Furthermore, a severe and potentially fatal condition including encephalitis, acute flaccid paralysis, myocarditis and hand-foot-mouth disease had been reported [812].

In the last two decades, echovirus18 (E18) and coxsackievirus B5 (CVB5), serotypes of HEV-B, have been isolated from sporadic and outbreak cases of aseptic meningitis in China, Taiwan, Germany, Korea, Australia and Palestine. These isolates were found to be associated with various degrees of illness among newborns, infants and school-age children, ranging from asymptomatic to fatal aseptic meningitis [1219].

The high mutation rate and the RNA recombination are responsible for genetic diversity of the enteroviruses [20].The recombination increases viral pathogenicity, eliminates lethal mutations and increases fitness of virus [20]. Of the four species, A, B, C and D, HEV-B was shown to have the highest rates of recombination particularly between members of the same species [2122].The few studies that investigated the molecular characterization of the two HEVs (E18 and CVB5), showed a wide range of genetic diversity in the VP1 region. The continuous diversity in the VP1 coding region, which is involved in virus–cell interactions and antibodies neutralization, might explain their continuous high endemicity and infection among the newborns, infants, children and adults [1418]. The aim of the present study was to identify the most predominant enteroviruses which circulated in the northern West Bank, Palestine in 2017 using RT-PCR followed by sequencing and to investigate the genetic diversity of the sequences of the partial VP1 region.

Materials and methods

Sample and data collection

During the period of March, 1stto October, 31th, 2017, 249 cerebrospinal fluid (CSF) specimens were collected from children admitted, with suspected aseptic meningitis, to Rafeedia governmental hospital in Nablus and Jenin governmental Hospital in Jenin and were store at -20°C until use. The inclusion criteria included all children with suspected aseptic meningitis showing headache, neck stiffness, low grade fever, and CSF with or without pleocytosis in the absence of an acute bacterial pathogen[23]. All CSF samples were proven negative for classical bacterial pathogens by the hospital microbiology laboratory. Patients’ demographic data and clinical history including age, sex, sign and symptoms, place of residence, date of onset of symptoms, and CSF laboratory test results were retrieved from the patients’ files. The study was approved by the Ministry of Health in Palestine under reference number ATM/125/2013 that included the approval of using the CSF samples and the clinical history from anonymous children. Undocumented verbal consent was taken in the presence of the physician and parents/guardians. This included informing all parties that this study was approved by Ministry of Health and only leftover samples following routine laboratory diagnosis will be used, which would normally be discarded, in order to achieve study objectives. Physician gave the order to provide leftover samples for the study. No additional samples will be requested for the study and all remaining samples will be discarded immediately after the study according to protocol. The data was analyzed anonymously.

Viral RNA extraction

The HEV RNA was extracted from 200 μl of CSF using a QIAamp viral RNA Mini Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer’s instructions.

RT-PCR

RT-PCR for HEV diagnosis

To identify the enterovirus associated aseptic meningitis cases, the HEV RNA was amplified using two primer sets targeting the 5’NCR of the HEV genome as described and modified previously[12, 24]. Briefly, one step RT-PCR test was carried out in 25μl- reaction mixture containing 5μl viral RNA extraction, 10 U Reverse transcriptase (AMV), 10 pmol of the outer primers (P1; 5’- GTA CCT TTG TGC GCC TGT T-3’ and P4; 5’-GAT GGC CAA TCC AAT AGC TA-3’) and 12.5μl of PCR Reddy master mix (Thermo Scientific). Two microliters from the first round were further amplified in 25μl reaction mixture containing 10 pmol of the inner primers (P2; 5’- TGG CTG CGT TGG CGG CCT G-3’ and P3; 5’-ACA CGG ACA CCC AAA GTA GTC GG) and 12.5μl of the PCR master mix (Thermo Scientific). In each PCR run, negative and positive controls were included. Five microliters of PCR product were analyzed by electrophoresis on a 2% agarose gel containing ethidium bromide and were visualized using the Gel Doc System 2000 (Bio-Rad Laboratories-Segrate, Milan, Italy). A band of 203 bp indicated a positive result.

RT-PCR for HEV genotyping

For HEV genotyping, an RT-PCR with two primer sets was used to amplify the 5’ half of the VP1region of the viral genome as described previously[12, 25]. Briefly, in the first round, a one-step RT-PCR was performed in 25 μl reaction mixture containing 20 pmol of the outer primers (EV-F; 5’- GYDGARACNGGVCACACRTC-3’ and EV-R; 5’ CTMATGAAHGGDATNGAYATBC-3’), 10 U AMV and 12.5 μl PCR master mix (Thermo Scientific). Two microliters from the first round was further amplified in 25μl reaction mixture containing 20 pmol of the inner two primers (ENTNES-F; 5’-GAYACWATGCARACVMGRCAYGT-3’ and ENTNES-R; 5’-GRGCAYTVCCYTCTGTCCA-3’) and 12.5 μl PCR master mix (Thermo Scientific). Negative and positive controls were used in each run. A band of 400 bp visualized on agarose gel electrophoresis indicated a positive result. PCR amplicons were purified using the NucleoSpin Gel and PCR Clean-up from Machery Nagel (Germany) before sending for commercial sequencing.

Enterovirus typing and phylogenetic analysis

The HEV identity was investigated by searching the partial VP1 sequences obtained in this study in comparison with the HEV prototypes and other HEVs sequences available in GenBank using basic local alignment (BLAST, http://www.ncbi.nlm.nih.gov/BLAST). The HEV that showed more than 75% nucleotide similarity was assigned to be the same genotype. Enterovirus Genotyping Tool version 1.0 was used to type positive samples (http://www.rivm.nl/mpf/enterovirus/typingtool/)[26]. Phylogenetic analyses of the RNA sequences of E18 and CVB5 genotypes were conducted based on the neighbor-joining (NJ) methods with Tamura-Nei and Kimura 2-parameter models implemented in MEGA 6 with 1000 bootstraps replicates for branch confidence in clades in each tree (Tamura et al., 2013). Poliovirus was used as an out-group.

Recombination analysis

The aligned E18 and CVB5 sequences were tested for any possible recombination events using the RDP 4 software [27]. All seven default statistical tools were employed including PHI statistic (Φw. or pairwise homoplasy index, PHI) [28], Geneconv [29], Bootscan [30], Max X2 [31], Chimaera [32], SiScan, and 3Seq [33]. P-value differs depending on the recombination test used, number of sequences analyzed where P-value is subsequently corrected by the RDP 4 default Bonferroni-correction. The recombination tests were performed using default settings and a Bonferroni-corrected P value cutoff of 0.05. The recombination analyses were confirmed by SplitTree 4 (ver. 4.14.6) software [34] using PHI statistic [28] and DnaSP 5.1 software [35].

Genetic diversity analysis and neutrality tests

To account for the limited number of genotype HEV cases (26) and the intermediate length of VP1 sequence (400bp) and the diversity that might be caused external factors such as amplifications and sequencing, several diversity indices were used [36]. The genetic diversity of the 13 E18 and the 11 CVB5 (9 in the present study and the 2 previously detected in 2013) detected in Palestine were analyzed based on VP1 gene. The 27 E18 from 10 different countries reported in the period of 1999–2017 and 25 CVB5 from 13 different countries reported in the period between 1971 and 2017 were retrieved from the Genebank and included in the analysis. EV18 and CVB5 RNA sequences were separately aligned using MEGA 6 [37]. Then, the genetic diversity of the VP1 gene in both E18 and CVB5 genotypes were calculated based on parameters including haplotype diversity (Hd), nucleotide diversity (π). Haplotype diversity (or gene diversity) refers to the number of haplotypes in the population. Nucleotide diversity is the average number of nucleotide differences per site in pairwise comparison between RNA sequences [38]. To detect departure from neutral theory of evolution (random mutation) at a constant population size, two neutrality tests were used. The first was Tajima's D test which compares the differences between the numbers of segregating sites (S) and the average number of nucleotide differences between two randomly chosen sequences from within in the population (K) [39]. The second test was Fu and Li's F test which compares differences between the number of singleton mutations and the average number of nucleotide differences between pairs of sequences [40]. DnaSP 5.1 software was used for the calculation at default settings. Although the number of isolates (sequences) is not fairly high, yet positive results were drawn with signs of genetic diversity.

Statistical analysis

Epidemiologic data were analyzed using EpiInfo statistical package. Analysis included distribution, 2x2 tables, and frequency tables. Fisher’s exact test and Chi square with 95% confidence interval were calculated. The level of statistical significance was P<0.05.

Results

Demography of circulating EVs

A total of 249 CSF samples were collected from hospitalized patients suspected of having aseptic meningitis in the period between March and October, 2017. Overall, 54/249 (22%) yielded positive results for HEV using RT-PCR targeting the 5’UTR. The general characteristic and the clinical history of the study samples are shown in Table 1.

Table 1. Demographic data and clinical history of the study samples.

Total 249
No. (%)
EV
54
Non-EV
195
Sex: )
Male 156 (62.5 33 123
Female 93 (27.5) 21 72
Age in month, median (range) 6 (0–92) 7 (0–92) 6 (0–90)
Place of residence: 156 (62.6) 26 (48.1) 130 (66.7)
Nablus 156 (62.6) 26 (48.1) 130 (66.7)
Jenin 93 (37.4) 28 (51.9) 65 (33.3)
CSF WBC’s, mean (range) 110 (0–3000) 379 (0–3000)* 19 (0–960)
Pleocytosis 50/179 (28) 13/40 (32.5) 37/110 (33.6)
Fever 233/249 (93.6) 50/54 (92.5) 179/195 (92)
Headache 66/249 (26.5) 33/54 (61)* 33/195 (17)
Diarrhea 53/249 (21.3) 20/54 (37)* 33/195 (16.9)
Vomiting and Nausea 82/249 (32.9) 26/54 (48.1)* 56/195 (28.7)
Stiff neck 18/249 (7.2) 13/54 (24)* 5/195 (2.5)
Photophobia 9/249 (3.6) 7/54 (13)* 2/195 (1%)
Mental disturbances 5/249 (2) 2/54 (3.7) 3/195 (1.5)

* P < 0.05

Twenty-six (48%) were successfully genotyped by sequencing the amplicon of the amplified 5’ VP1 region. Four different types of HEVs were detected. All of them belong to HEV-B species. Thirteen of the detected HEVs (50%) were E18, 9 (34.5%) were coxsackievirus B5 (CVB5), 3 (11.5%) were E25 and 1 (3.8%) was CVB2. Demographic data, the clinical history and the gene Bank accession number of the genotypes HEV cases are shown in Table 2.

Table 2. Demographic data and clinical characteristic of the diagnosed HEVs genotypes.

Sample No. Accession No. EV genotype Month/year of isolation Age (month) District
170J/017 MG773498 E18 04/2017 33 Jenin
186J/017 MG773499 E18 05/2017 64 Jenin
188J/017 MG773500 E18 05/2017 16.5 Jenin
208N/017 MG773501 E18 05/2017 70 Nablus
227J/017 MG773502 E18 07/2017 57 Jenin
232J/017 MG773503 E18 08/2017 3 Jenin
247J/017 MG773504 E18 07/2017 5 Jenin
257J/017 MG773505 E18 08/2017 81 Jenin
262J/017 MG773506 E18 08/0217 67 Jenin
265J/017 MG773507 E18 08/2017 3 Jenin
344J/017 MG773508 E18 04/2017 6 Jenin
376J/017 MG773509 E18 09/2017 77 Jenin
380J/017 MG773510 E18 08/2017 10.5 Jenin
206N/017 MG773497 CVB5 05/2017 40 Nablus
230J/017 MG773489 CVB5 07/2017 75.5 Jenin
211N/017 MG773511 CVB2 05/2017 <1 Nablus
260J/017 MG773490 CVB5 06/2017 <1 Jenin
338N/017 MG773491 CVB5 04/2017 4 Nablus
342J/017 MG773492 CVB5 05/2017 1 Jenin
345J/017 MG773495 CVB5 05/2017 21 Jenin
354N/017 MG773496 CVB5 04/2017 35 Nablus
407N/017 MG773494 CVB5 03/2017 1 Nablus
433N/017 MG773493 CVB5 04/2017 49 Nablus
261/017 MG773514 E25 05/2017 42 Jenin
299N/017 MG773512 E25 06/2017 6 Nablus
389J/017 MG773513 E25 09/2017 51 Jenin

Phylogenetic analysis of the partial VP1 gene of the E18 and CVB5

Phylogenetic analysis of the partial VP1 gene was conducted using the thirteen E18 and eleven CVB5 strains from Palestine (9 in 2017 and 2 in 2013). Twenty-seven E18 and 25 CVB5 sequences were retrieved from GenBank were included for comparison. The phylogenetic tree for E18 showed three main clusters with all Palestinian isolates uniquely clustering together along with those from China. Similarly, The CVB5 isolates were distributed into three clusters with Palestinian isolates in 2017 clustering together, along with isolates from different areas of the world, whereas, the two Palestinian isolates in 2013 grouped within the Predominantly-Chinese cluster (Fig 1)

Fig 1. Bootstrap consensus (1000 replicates) neighbor joining (NJ) phylogenetic dendrograms constructed based on the partial VP1 gene of E18 (left) and CVB5 (right).

Fig 1

Dendrograms for E18 (○) and CVB5 (□) are plotted against the global distribution of the geographical origin of the isolates. The two clusters contain strains from Palestine (Δ) along with strains from GenBank. Poliovirus from vaccine was included as an out-group [41].

Recombination analysis

The recombination analysis did not find any statistically significant evidence for recombination events between the aligned sequences, both on the Palestinian strains level (13 E18 strains and 11 CVB5) and international level that included Palestinian strains pooled with strains from the Gene bank (40E18 strains and 36CVB5). However, minimum number of recombination events was detected by DnaSP 5.1 software for E18 and CVB5. RDP4 software (PHI statistic) revealed good chance of recombination, but at a very low P-value (0.00001).

Diversity indices

Population nucleotide diversity indices and neutrality tests were calculated for the partial VP1 gene for E18 and CVB5, separately, based on phylogenetic clusters (Tables 3 and 4). The totally haplotype diversity (Hd) for the 40 E18 sequences was 0.98± 0.01 and 0.99± 0.006 for the 36CVB5. At the same time, the total genetic diversity (π) for E18 was 0.12± 0.02 and 0.17± 0.01 for CVB5. The average number of nucleotide differences between any two sequences (k) for E18 and CVB5 were 35.5 and 41, respectively. Cluster I of E18 showed peculiar results compared to the other two clusters. In this group, we detected 12 haplotypes in 19 sequences with the lowest haplotype-to-sequence (h:n) ratio (0.6:1), compared to equal h:n ratio for clusters II and III. Haplotype diversity (Hd), nucleotide diversity (π), and number of segregating (polymorphic) sites (S) for E18 were lowest in cluster I which is comprised mainly of Palestinian strains (13/19) along with those from China; confirming low level of genetic diversity present in this cluster compared to clusters II and III. Tajima’s D and Fu-Li’sF tests were negative in cluster I and showing statistically significant departure from neutrality (random mutation) (P<0.01). As for CVB5 genotype, cluster III recorded the lowest genetic diversity indices and neutrality tests with negative but insignificant values (Tables 3 and 4). Both E18 and CVB5 showed a combination of high haplotype diversity (Hd), but low genetic diversity (π). Also, both showed overall negative values of neutrality tests; Tajima’s D and Fu-Li’s F.

Table 3. Haplotype-nucleotide diversity and neutrality tests of three cluster of E18 as calculated for the VP1 gene.

Haplotype- nucleotide diversity Neutrality tests
Cluster n h h:n Hd±SD π±SD K S Tajima’s D Fu-Li’s F
RED-I 19 12 0.6:1 0.92± 0.05 0.03± 0.01 11.3 67 -1.80* -2.97*
Green-II 7 7 1:1 1.0± 0.08 0.07± 0.01 61.9 165 -0.57 -0.56
Blue-III 10 9 0.9:1 1.0± 0.05 0.06± 0.01 55.2 171 -0.93 -1.12
Total 41 34 0.9:1 0.98± 0.01 0.12± 0.02 35.5 184 -1.50 -2.80

n: Number of sequences, h: Number of Haplotypes, Hd: Haplotype (gene) diversity, π: Nucleotide diversity (per site), K: Average number of nucleotide differences between two randomly chosen sequences from within in the population, S: Number of variable/segregating sites. (1 outgroup, 4 have no clear cluster).

*: P<0.01.

Table 4. Haplotype/nucleotide diversity and neutrality tests of three cluster of CVB5 as calculated for the VP1 gene.

Haplotype nucleotide diversity Neutrality tests
Cluster n h n:h Hd±SD π±SD K S Tajima’s D Fu-Li’s F
Blue-I 14 14 1:1 1.0± 0.03 0.13± 0.009 89.3 89 0.05 0.36
Green-II 13 13 1:1 1.0± 0.03 0.10± 0.01 28.3 74 -0.257 -0.27
RED-III 19 18 1:1 0.94± 0.02 0.08± 0.007 24.3 75 -0.55 -1.13
Total 46 45 1:1 0.99± 0.006 0.17± 0.01 41.04 133 -0.75 -1.76

n: Number of sequences, h: Number of Haplotypes, Hd: Haplotype (gene) diversity, π: Nucleotide diversity (per site), K: Average number of nucleotide differences between two randomly chosen sequences from within in the population, S: Number of variable/segregating sites. (1 outgroup, 4 have no clear cluster)

Inter-population pairwise genetic distance (Fst) in the three E18 populations ranged from 0.39 to 0.63 with Nm value from 0.29 to 0.78 (Tables 5 and 6). Fst for cluster I containing all Palestinian strains compared to clusters II and III were high (0.51 and 0.63) (positive Tajima’s D) indicating population differentiation with low gene flow, Nm (0.48 and 0.29). However, genetic differentiation between clusters II and III is low (Fst = 0.39) with high Nm (0.78), but still reflected genetic differentiation. This is supported by the negative value of Gst (-0.006).

Table 5. Gene flow and genetic differentiation indices between the three E18 clusters estimated from VP1 sequences.

Phylogroup 1 Phylogroup 2 Fst Nm Kxy Dxy Gst Da
Red-I Green-II 0.51 0.48 30.6 0.09 0.029 0.05
Red-I Blue-III 0.63 0.29 39.7 0.13 0.024 0.08
Blue -III Green-II 0.39 0.78 30.2 0.09 -0.006 0.04

Fst: Wright’s F-statistics, pairwise genetic distance, Nm: Gene flow and population migration among populations which is calculated as Nm = (1-Fst)/2Fst, Kxy: Average proportion of nucleotide differences between populations. Dxy: The average number of nucleotide substitutions per site between populations, Da: The number of net nucleotide substitutions per site between populations, Gst: Genetic differentiation index based on the frequency of haplotypes.

Table 6. Gene flow and genetic differentiation indices between the three CB5 clusters estimated from VP1 sequences.

Phylogroup 1 Phylogroup 2 Fst Nm Kxy Dxy Gst Da
Red-III Green-II 0.54 0.43 48.8 0.19 0.005 0.11
Red-III Blue-I 0.49 0.52 51.8 0.21 0.005 0.10
Blue-I Green-II 0.32 1.06 43.9 0.18 0.00005 0.06

Fst: Wright’s F-statistics, pairwise genetic distance, Nm: Gene flow and population migration among populations which is calculated as Nm = (1-Fst)/2Fst, Kxy: Average proportion of nucleotide differences between populations Dxy: The average number of nucleotide substitutions per site between populations, Da: The number of net nucleotide substitutions per site between populations, Gst: Genetic differentiation index based on the frequency of haplotypes.

As for CVB5, cluster III which contained most of the Palestinian strains is differentiated from the other two clusters, I and II, as reflected by the high Fst and low Nm values (Fst = 0.54, Nm = 0.43) and (Fst = 0.49 and 0.52), respectively. At the same time, the genetic differentiation between clusters I and II is relatively low as supported by very low Gst value (Gst = 0.00005) and relatively low Fst (0.32) with high gene flow (Nm = 1.06).

Discussion

So far, only one report in Palestine confirmed the isolation of 7 different enteroviruses genotypes including echovirus 13, 14, 9, 30, 16, 6 and coxsackievirus B5 from sporadic cases of aseptic meningitis and/or sepsis like illness [12]. In the present study, all of the HEV positive cases occurred in children less than 7 years old and 50% of them < 1-year-old. Highest rate of enterovirus-positive cases was reported previously in children less than 1 year of age in Palestine, United States, and Korea [12, 42]. On the contrary, other studies, reported that HEV aseptic meningitis occurs most frequently in patients with age range of 3–12 years’ old [1517, 43]. The discrepancy in the HEV age groups could be due to the source of cases whether sporadic or from an outbreak.

The present study showed that E18 and CVB5 were the most predominant genotypes, representing, 50% and 34.6% respectively. Several recent studies in Germany, Taiwan, Korea, and China reported that both E18 and CVB5 were the most predominant HEVs reported from sporadic and outbreak cases of aseptic meningitis [15, 1718, 44].

All E18 sequences included in the phylogenetic analysis grouped into three major genetic clusters. The E18 isolates from Palestine clustered together along with those from China reported in 2015 in cluster I. Clusters II and III contain E18 from Australia, France, USA, Sweden, Russian, Germany and Netherlands reported in the periods 2005–2012 and 1999–2012, respectively. Other minor clusters included cluster IV and V which included the prototype Metacalf and few HEV reported from India and China in the period 2000–2008. The low number of E18 isolates in clusters IV and V is due to low number of the E18 included in the phylogenetic analysis. Similar results reported a genetic divergence in the complete VP1 gene of the E18 that resulted in the formation of five phylogenetic clusters [44]. These viruses were reported recently from China, India, South Korea, Australia, Netherlands, Germany, Sweden, Russia and France [44]. Phylogenetic analysis of partial or complete VP1 gene of E11, E30, E13, and E6 of the HEV-B species revealed high genetic diversity showing several clusters and sub-clusters [44]. Accordingly, such data indicate that the same HEV genotype may circulate in different geographies at different times. Therefore, and due to lack of reporting HEVs in Palestine, the possibility of knowing whether E18 isolates in cluster I are recently imported or have already been circulating before remains a dilemma.

The CVB5 sequences grouped into three genetic clusters (Fig 1). Cluster III contained the 9 Palestinian strains isolated in 2017 along with CVB5 from Brazil, France, Cyprus, Germany and Australia reported in the period from 2006 to 2017. The 2 Palestinian isolates in 2013 grouped with a more recent CVB5 in cluster II (2003–2014) from China, Denmark, France and Netherland. Cluster I contained the prototype Faulkner and isolates from France, Germany, Japan, Korea, China, Hong Kong, India, Finland and Sweden. Recently, few studies compared the partial or the complete VP1 gene revealing genetic diversity of CVB5 in 2–5 clusters [4547]. Accordingly, the findings in the present study reaffirm that two or more clusters may co-circulate and co-evolve in the same region as a result of the genetic diversity forces such as mutation or recombination.

The recombination for both species E18 and CVB5 was minimal, if at all present between the study sequences which could be explained by the infrequency of recombination within the capsid region, VP1, low level of co-infection, different tissue tropism, low level of viral prevalence, low geographic differences in the occurrences of virus, high nucleotide similarity in viral genome, presence of transcriptional factors and proteins like Cis-acting elements [2122, 48]. However, it is worth mentioning that recombination analysis was based on partial VP1 sequence (400 nt) and not on complete sequence of the gene. This puts forward mutation rates as the main cause of genetic diversity. The significant departure from neutrality as confirmed by negative Tajima’s D and Fu-Li’s F accompanied by high haplotype (Hd) and low nucleotide diversity (π) for cluster I of E18 (Table 3) may suggest recent rapid population expansion phase following bottleneck or genetic hitchhiking (genetic draft or gene sweep) that bring excess number of rare alleles. This was supported by the negative values Tajima’s D and Fu-Li’s F tests in the individual populations and the overall value for the three populations. A study in Taiwan showed that partial VP1 genes of E18 have low genetic diversity with high similarity between regions [16]. The clustering of the Palestinian and Chinese isolates in cluster I could have been brought about by the activity of Palestinian traders to China and back. Cluster II and III had similar diversity indices, but without any significance.

Cluster III of CVB5 showed lower genetic diversity than the others (Table 4), yet insignificant; suggesting that cluster III may have undergone a neutral or contraction period or may be due to small subpopulations with limited number of sequences to yield sufficient statistical power. A study from Korea revealed very high similarity in the partial VP1 sequences among Korean samples (intra-population similarity) and between Chinese strains (inter-population similarity) [18]. The genetic similarity of the Palestinian, Korean and Taiwanese E18 and CVB5 strains to those from China, may hint to their dispersal from China to the rest of the world [16, 18]. However, a more extensive study of several endemic areas should be conducted to confirm the ancestral origin of E18 and CVB5, the route of spread and the distribution.

The estimations of inter-population comparison indices (Fst, Nm, Kxy, Dxy, Gst and Da) (Tables 5 and 6) support high level of genetic differentiation between the three main clusters of both E18 and CVB5. These results are supportive of the cluster in phylogenetic analyses (Fig 1).

In conclusion, the present study unravels three main clusters for each of the E18 and CVB5 with both showing high haplotype diversity compared to lower genetic diversity. The Palestinian isolates grouped mainly into one cluster for each viral species. Finally, present study supports close genetic relationship between Palestinian HEV species as confirmed by population genetics and phylogenetic analyses.

Data Availability

All relevant data are within the paper.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Pallansch M, Oberste MS, Whitton JL. Enteroviruses as agents of emerging infectious diseases In: Knipe DM, Howley P.M, I, CJ, Griffin D.E, Lamb R.A, Martin M.A et al. , ed., editor. Fields Virology. Sixth ed. Philadelphia: Wolters Klewer; / Lippincott Williams & Wilkinspp; 2013. p. 490–530. [Google Scholar]
  • 2.The Pirbright Institute, UK. Picornaviridae 2018. Available from: http://www.picornaviridae.com/.
  • 3.Knowles NJ, Hovi T, Hyypiä T, King AMQ, Lindberg AM, Pallansch MA, editors. Virus taxonomy: classification and nomenclature of viruses: ninth report of the international committee on taxonomy of viruses. San Diego: Elsevier; 2012. [Google Scholar]
  • 4.Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA. Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol. 1999;37(5):1288–93. Epub 1999/04/16. ; PubMed Central PMCID: PMC84754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Harvala H, Calvert J, Van Nguyen D, Clasper L, Gadsby N, Molyneaux P, et al. Comparison of diagnostic clinical samples and environmental sampling for enterovirus and parechovirus surveillance in Scotland, 2010 to 2012. Euro Surveill. 2014;19(15). Epub 2014/04/26. . [DOI] [PubMed] [Google Scholar]
  • 6.Othman I, Volle R, Elargoubi A, Guediche MN, Chakroun M, Sfar MT, et al. Enterovirus meningitis in Tunisia (Monastir, Mahdia, 2011–2013): identification of virus variants cocirculating in France. Diagn Microbiol Infect Dis. 2016;84(2):116–22. Epub 2015/12/09. doi: S0732-8893(15)00390-9 [pii] 10.1016/j.diagmicrobio.2015.10.019 . [DOI] [PubMed] [Google Scholar]
  • 7.Xiao H, Guan D, Chen R, Chen P, Monagin C, Li W, et al. Molecular characterization of echovirus 30-associated outbreak of aseptic meningitis in Guangdong in 2012. Virol J. 2013;10:263. Epub 2013/08/24. doi: 1743-422X-10-263 [pii] 10.1186/1743-422X-10-263 ; PubMed Central PMCID: PMC4016494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Logotheti M, Pogka V, Horefti E, Papadakos K, Giannaki M, Pangalis A, et al. Laboratory investigation and phylogenetic analysis of enteroviruses involved in an aseptic meningitis outbreak in Greece during the summer of 2007. J Clin Virol. 2009;46(3):270–4. Epub 2009/08/25. doi: S1386-6532(09)00371-0 [pii] 10.1016/j.jcv.2009.07.019 . [DOI] [PubMed] [Google Scholar]
  • 9.Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43(12):1565–77. Epub 2006/11/17. doi: CID40366 [pii] 10.1086/509330 . [DOI] [PubMed] [Google Scholar]
  • 10.Laxmivandana R, Yergolkar P, Gopalkrishna V, Chitambar SD. Characterization of the non-polio enterovirus infections associated with acute flaccid paralysis in South-Western India. PLoS One. 2013;8(4):e61650 Epub 2013/05/01. 10.1371/journal.pone.0061650 PONE-D-12-29166 [pii]. ; PubMed Central PMCID: PMC3632520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lang M, Mirand A, Savy N, Henquell C, Maridet S, Perignon R, et al. Acute flaccid paralysis following enterovirus D68 associated pneumonia, France, 2014. Euro Surveill. 2014;19(44). Epub 2014/11/14. . [DOI] [PubMed] [Google Scholar]
  • 12.Dumaidi K, Al-Jawabreh A. Molecular detection and genotyping of enteroviruses from CSF samples of patients with suspected sepsis-like illness and/or aseptic meningitis from 2012 to 2015 in West Bank, Palestine. PLoS One. 2017;12(2):e0172357 Epub 2017/02/23. 10.1371/journal.pone.0172357 PONE-D-16-32173 [pii]. ; PubMed Central PMCID: PMC5321419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chen X, Li J, Guo J, Xu W, Sun S, Xie Z. An outbreak of echovirus 18 encephalitis/meningitis in children in Hebei Province, China, 2015. Emerg Microbes Infect. 2017;6(6):e54. Epub 2017/06/22. doi: emi201739 [pii] 10.1038/emi.2017.39 ; PubMed Central PMCID: PMC5584482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zhu Y, Zhou X, Liu J, Xia L, Pan Y, Chen J, et al. Molecular identification of human enteroviruses associated with aseptic meningitis in Yunnan province, Southwest China. Springerplus. 2016;5(1):1515 Epub 2016/09/22. 10.1186/s40064-016-3194-1 3194 [pii]. ; PubMed Central PMCID: PMC5016492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Liu N, Jia L, Yin J, Wu Z, Wang Z, Li P, et al. An outbreak of aseptic meningitis caused by a distinct lineage of coxsackievirus B5 in China. Int J Infect Dis. 2014;23:101–4. Epub 2014/04/22. doi: S1201-9712(14)01441-6 [pii] 10.1016/j.ijid.2014.02.005 . [DOI] [PubMed] [Google Scholar]
  • 16.Tsai HP, Huang SW, Wu FL, Kuo PH, Wang SM, Liu CC, et al. An echovirus 18-associated outbreak of aseptic meningitis in Taiwan: epidemiology and diagnostic and genetic aspects. J Med Microbiol. 2011;60(Pt 9):1360–5. Epub 2011/05/07. doi: jmm.0.027698–0 [pii] 10.1099/jmm.0.027698-0 . [DOI] [PubMed] [Google Scholar]
  • 17.Krumbholz A, Egerer R, Braun H, Schmidtke M, Rimek D, Kroh C, et al. Analysis of an echovirus 18 outbreak in Thuringia, Germany: insights into the molecular epidemiology and evolution of several enterovirus species B members. Med Microbiol Immunol. 2016;205(5):471–83. Epub 2016/07/03. 10.1007/s00430-016-0464-z 10.1007/s00430-016-0464-z [pii]. . [DOI] [PubMed] [Google Scholar]
  • 18.Baek K, Park K, Jung E, Chung E, Park J, Choi H, et al. Molecular and epidemiological characterization of enteroviruses isolated in Chungnam, Korea from 2005 to 2006. J Microbiol Biotechnol. 2009;19(9):1055–64. Epub 2009/10/08. doi: JMB019-09-28 [pii]. . [DOI] [PubMed] [Google Scholar]
  • 19.Huang B, Harrower B, Burtonclay P, Constantino T, Warrilow D. Genome Sequences of Coxsackievirus B5 Isolates from Two Children with Meningitis in Australia. Genome Announc. 2017;5(41). Epub 2017/10/14. doi: 5/41/e01125-17 [pii] 10.1128/genomeA.01125-17 ; PubMed Central PMCID: PMC5637508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Muslin C, Joffret ML, Pelletier I, Blondel B, Delpeyroux F. Evolution and Emergence of Enteroviruses through Intra- and Inter-species Recombination: Plasticity and Phenotypic Impact of Modular Genetic Exchanges in the 5' Untranslated Region. PLoS Pathog. 2015;11(11):e1005266 Epub 2015/11/13. 10.1371/journal.ppat.1005266 PPATHOGENS-D-15-01590 [pii]. ; PubMed Central PMCID: PMC4643034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lukashev AN. Role of recombination in evolution of enteroviruses. Rev Med Virol. 2005;15(3):157–67. Epub 2004/12/04. 10.1002/rmv.457 . [DOI] [PubMed] [Google Scholar]
  • 22.Simmonds P, Welch J. Frequency and dynamics of recombination within different species of human enteroviruses. J Virol. 2006;80(1):483–93. Epub 2005/12/15. doi: 80/1/483 [pii] 10.1128/JVI.80.1.483-493.2006 ; PubMed Central PMCID: PMC1317522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.World Health Organization. The ICD-10 classification of diseases and health problems: Chapter VI: Diseases of the nervous system: Geneva: World Health Organization; 2016. [Google Scholar]
  • 24.Guney C, Ozkaya E, Yapar M, Gumus I, Kubar A, Doganci L. Laboratory diagnosis of enteroviral infections of the central nervous system by using a nested RT-polymerase chain reaction (PCR) assay. Diagn Microbiol Infect Dis. 2003;47(4):557–62. Epub 2004/01/09. doi: S0732889303001482 [pii]. . [DOI] [PubMed] [Google Scholar]
  • 25.Thoelen I, Lemey P, Van Der Donck I, Beuselinck K, Lindberg AM, Van Ranst M. Molecular typing and epidemiology of enteroviruses identified from an outbreak of aseptic meningitis in Belgium during the summer of 2000. J Med Virol. 2003;70(3):420–9. Epub 2003/05/27. 10.1002/jmv.10412 . [DOI] [PubMed] [Google Scholar]
  • 26.Kroneman A, Vennema H, Deforche K, v d Avoort H, Penaranda S, Oberste MS, et al. An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol. 2011;51(2):121–5. Epub 2011/04/26. doi: S1386-6532(11)00129-6 [pii] 10.1016/j.jcv.2011.03.006 . [DOI] [PubMed] [Google Scholar]
  • 27.Martin D, Rybicki E. RDP: detection of recombination amongst aligned sequences. Bioinformatics. 2000;16(6):562–3. Epub 2000/09/12. . [DOI] [PubMed] [Google Scholar]
  • 28.Bruen TC, Philippe H, Bryant D. A simple and robust statistical test for detecting the presence of recombination. Genetics. 2006;172(4):2665–81. Epub 2006/02/21. doi: genetics.105.048975 [pii] 10.1534/genetics.105.048975 ; PubMed Central PMCID: PMC1456386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sawyer SA. Geneconv: a computer package for the statistical detection of gene conversion. Department of Mathematics. Washington University in St Louis; http://www.math.wustl.edu/sawyer; 1999. [Google Scholar]
  • 30.Salminen MO, Carr JK, Burke DS, McCutchan FE. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses. 1995;11(11):1423–5. Epub 1995/11/01. 10.1089/aid.1995.11.1423 . [DOI] [PubMed] [Google Scholar]
  • 31.Smith JM. Analyzing the mosaic structure of genes. J Mol Evol. 1992;34(2):126–9. Epub 1992/02/01. . [DOI] [PubMed] [Google Scholar]
  • 32.Posada D, Crandall KA. Evaluation of methods for detecting recombination from DNA sequences: computer simulations. Proc Natl Acad Sci U S A. 2001;98(24):13757–62. Epub 2001/11/22. 10.1073/pnas.241370698 [pii]. ; PubMed Central PMCID: PMC61114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Martin DP, Williamson C, Posada D. RDP2: recombination detection and analysis from sequence alignments. Bioinformatics. 2005;21(2):260–2. Epub 2004/09/21. 10.1093/bioinformatics/bth490 bth490 [pii]. . [DOI] [PubMed] [Google Scholar]
  • 34.Huson DH, Bryant D. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 2006;23(2):254–67. Epub 2005/10/14. doi: msj030 [pii] 10.1093/molbev/msj030 . [DOI] [PubMed] [Google Scholar]
  • 35.Hudson RR, Kaplan NL. Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics. 1985;111(1):147–64. Epub 1985/09/01. ; PubMed Central PMCID: PMC1202594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Thai KT, Henn MR, Zody MC, Tricou V, Nguyet NM, Charlebois P, et al. High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections. J Virol. 2012;86(2):835–43. Epub 2011/11/18. doi: JVI.05985-11 [pii] 10.1128/JVI.05985-11 ; PubMed Central PMCID: PMC3255838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30(12):2725–9. Epub 2013/10/18. doi: mst197 [pii] 10.1093/molbev/mst197 ; PubMed Central PMCID: PMC3840312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Nei M, editor. Molecular evolutionary genetics. New York: Colombia University Press; 512 p.M.1987. [Google Scholar]
  • 39.Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123(3):585–95. Epub 1989/11/01. ; PubMed Central PMCID: PMC1203831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Fu YX, Li WH. Statistical tests of neutrality of mutations. Genetics. 1993;133(3):693–709. Epub 1993/03/01. ; PubMed Central PMCID: PMC1205353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Wikimedia Commons, the free media repository, cartographers. File:World map blank without borders.svg. (2018, January 4). Retrieved 05:08, September 9, 2018 from https://commons.wikimedia.org/w/index.php?title=File:World_map_blank_without_borders.svg&oldid=276775518.2018.
  • 42.Sawyer MH, Holland D, Aintablian N, Connor JD, Keyser EF, Waecker NJ Jr. Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr Infect Dis J. 1994;13(3):177–82. Epub 1994/03/01. . [DOI] [PubMed] [Google Scholar]
  • 43.Muehlenbachs A, Bhatnagar J, Zaki SR. Tissue tropism, pathology and pathogenesis of enterovirus infection. J Pathol. 2015;235(2):217–28. Epub 2014/09/12. 10.1002/path.4438 . [DOI] [PubMed] [Google Scholar]
  • 44.Zhang H, Zhao Y, Liu H, Sun H, Huang X, Yang Z, et al. Molecular characterization of two novel echovirus 18 recombinants associated with hand-foot-mouth disease. Sci Rep. 2017;7(1):8448 Epub 2017/08/18. 10.1038/s41598-017-09038-y [pii]. ; PubMed Central PMCID: PMC5559515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Gullberg M, Tolf C, Jonsson N, Mulders MN, Savolainen-Kopra C, Hovi T, et al. Characterization of a putative ancestor of coxsackievirus B5. J Virol. 2010;84(19):9695–708. Epub 2010/07/16. doi: JVI.00071-10 [pii] 10.1128/JVI.00071-10 ; PubMed Central PMCID: PMC2937801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Papa A, Skoura L, Dumaidi K, Spiliopoulou A, Antoniadis A, Frantzidou F. Molecular epidemiology of Echovirus 6 in Greece. Eur J Clin Microbiol Infect Dis. 2009;28(6):683–7. Epub 2009/01/09. 10.1007/s10096-008-0685-1 . [DOI] [PubMed] [Google Scholar]
  • 47.Rezig D, Fares W, Seghier M, Yahia AB, Touzi H, Triki H. Update on molecular characterization of coxsackievirus B5 strains. J Med Virol. 2011;83(7):1247–54. Epub 2011/05/14. 10.1002/jmv.22084 . [DOI] [PubMed] [Google Scholar]
  • 48.Smura T, Blomqvist S, Vuorinen T, Ivanova O, Samoilovich E, Al-Hello H, et al. Recombination in the evolution of enterovirus C species sub-group that contains types CVA-21, CVA-24, EV-C95, EV-C96 and EV-C99. PLoS One. 2014;9(4):e94579 Epub 2014/04/12. 10.1371/journal.pone.0094579 PONE-D-13-46351 [pii]. ; PubMed Central PMCID: PMC3983234. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data are within the paper.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES